Restructuring (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Sep. 25, 2015	Jan. 29, 2015
Restructuring Cost and Reserve [Line Items]
Impairment of intangible assets	$ 155,943,000
2015 US Generic Pharmaceuticals Restructuring
Restructuring Cost and Reserve [Line Items]
Expected positions eliminated (percent)				6.00%
Restructuring expenses	3,464,000	$ 0
Restructuring reserve	17,322,000		$ 17,914,000
2015 US Generic Pharmaceuticals Restructuring | Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Expected accelerated depreciation restructuring expenses	9,800,000
2015 US Generic Pharmaceuticals Restructuring | Employee Severance and Other Benefit-Related Costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring costs remaining	1,600,000
2016 US Generic Pharmaceuticals Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	127,200,000
Expected restructuring costs	200,000,000
2016 US Generic Pharmaceuticals Restructuring | Asset Impairment Charges
Restructuring Cost and Reserve [Line Items]
Impairment of intangible assets	100,300,000
2016 US Generic Pharmaceuticals Restructuring | Inventory Write-Offs
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	26,900,000
Auxilium Restructuring
Restructuring Cost and Reserve [Line Items]
Expected positions eliminated (percent)					40.00%
Restructuring reserve	8,664,000		12,263,000
Auxilium Restructuring | Employee Severance and Other Benefit-Related Costs
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	$ 2,131,000		$ 5,353,000